Publication

A comparison of clinical outcomes from updated Zuma-5 (Axicabtagene Ciloleucel) and the international scholar-5 external control cohort in relapsed/refractory follicular lymphoma (R/R FL)

Palomba, M. L.
; 
Ghione, P.
; 
Patel, A. R.
; 
Deighton, K.
; 
Jacobson, C.
; 
Nahas, M.
; 
Jung, A. S.
; 
Hatswell, A. J.
; 
Kanters, S.
; 
Limbrick-Oldfield, E.
... show 8 more
Citations
Altmetric:
Abstract
Authors
Palomba, M. L.
Ghione, P.
Patel, A. R.
Deighton, K.
Jacobson, C.
Nahas, M.
Jung, A. S.
Hatswell, A. J.
Kanters, S.
Limbrick-Oldfield, E.
Wade, S. W.
Snider, J. T.
Neelapu, S. S.
Riberio, M. T.
Gribben, J.
Radford, John A
Bobillo, S.
Ghesquieres, H.
Affiliation
Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Description
Date
2021
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Palomba ML, Ghione P, Patel AR, Deighton K, Jacobson C, Nahas M, et al. A Comparison of Clinical Outcomes from Updated Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL). Blood. 2021 Nov;138. PubMed PMID: WOS:000736413906109.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/625653
Embedded videos